(Q40031313)

16 September 2017

title

Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor (English)

1 reference

16 September 2017

4

Xiaoyuan Chen

1 reference

16 September 2017

1

Gang Niu

1 reference

16 September 2017

2

Weibo Cai

1 reference

16 September 2017

Kai Chen

3

1 reference

16 September 2017

publication date

22 December 2007

1 reference

Molecular Imaging and Biology

16 September 2017

published in

1 reference

16 September 2017

volume

10

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

99-106

1 reference

https://scigraph.springernature.com/pub.10.1007/s11307-007-0123-2

16 September 2017

exact match

0 references

cites work

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-007-0123-2

Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-007-0123-2

Use of specimen mammography-guided FNA (fine-needle aspirates) for flow cytometric multiple marker analysis and immunophenotyping in breast cancer

21 January 2018

1 reference

12 December 2020

Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.

1 reference

12 December 2020

Cell signaling by receptor tyrosine kinases

1 reference

12 December 2020

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

1 reference

12 December 2020

17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts

1 reference

12 December 2020

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET

1 reference

12 December 2020

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

12 December 2020

Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.

1 reference

12 December 2020

In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.

1 reference

12 December 2020

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo

1 reference

12 December 2020

Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery

1 reference

12 December 2020

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

12 December 2020

Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates

1 reference

12 December 2020

Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics

1 reference

12 December 2020

The language of covalent histone modifications

1 reference

12 December 2020

Targeting the HER-kinase axis in cancer

1 reference

12 December 2020

Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70

1 reference

12 December 2020

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy

1 reference

12 December 2020

Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228

1 reference

12 December 2020

Targeting HER1/EGFR: a molecular approach to cancer therapy

1 reference

12 December 2020

Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity

1 reference

12 December 2020

Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice

1 reference

12 December 2020

Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases

1 reference

12 December 2020

Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy

1 reference

12 December 2020

Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A

1 reference

12 December 2020

PET of vascular endothelial growth factor receptor expression.

1 reference

12 December 2020

Hsp90: a novel target for cancer therapy

1 reference

12 December 2020

Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors.

1 reference

12 December 2020

In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice

1 reference

12 December 2020

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90

1 reference

12 December 2020

Perspectives on anti-HER monoclonal antibodies

1 reference

12 December 2020

Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression

1 reference

12 December 2020

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

12 December 2020

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

12 December 2020

Early detection of bleomycin-induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1

1 reference

12 December 2020

Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases

1 reference

12 December 2020

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

1 reference

12 December 2020

10.1007/S11307-007-0123-2

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

1017145925

0 references

1 reference